During the past decade, Bridger Orthopaedic and Sports Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bridger Orthopaedic and Sports Medicine" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator and "Vanderbilt University Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Bridger Orthopaedic and Sports Medicine" are "Degenerative and Traumatic Pathology of the Foot and Ankle" (1 trials), "Degenerative and Traumatic Pathology of the Hand and Wrist" (1 trials), "Degenerative and Traumatic Pathology of the Hip" (1 trials), "Degenerative and Traumatic Pathology of the Knee" (1 trials) and "Degenerative and Traumatic Pathology of the Shoulder and Elbow" (1 trials). Many other conditions were trialed in "Bridger Orthopaedic and Sports Medicine" in a lesser frequency.

The vast majority of trials in "Bridger Orthopaedic and Sports Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bridger Orthopaedic and Sports Medicine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bridger Orthopaedic and Sports Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bridger Orthopaedic and Sports Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".